Gene Therapies Market Report: Details about Current Status, Relative Clinical and Commercial Success, Strategic … – Digital Journal
|
Gene Therapies Market Report: Details about Current Status, Relative Clinical and Commercial Success, Strategic …
Digital Journal The pipeline for gene therapies is robust; there are 985 in vivo gene therapies, and a further 354 CAR-T cell therapies currently in pipeline development. Most are at an early stage of development, with 76% at the Discovery or Preclinical stage. There … |
